Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Lantern Pharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LTRN.
You can purchase shares of Lantern Pharma (NASDAQ:LTRN) through any online brokerage.
Other companies in Lantern Pharma’s space includes: Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), FibroGen (NASDAQ:FGEN), Barinthus Biotherapeutics (NASDAQ:BRNS) and MAIA Biotechnology (AMEX:MAIA).
Lantern Pharma has a consensus price target of $11.00.
The stock price for Lantern Pharma (NASDAQ: LTRN) is $3.58 last updated March 17, 2025 at 7:10 AM EDT.
There are no upcoming dividends for Lantern Pharma.
Lantern Pharma’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Lantern Pharma.
Lantern Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.